Evidence map›Paper›PMID 40150813›Full record

ReviewMedical science monitor : international medical journal of experimental and clinical research2025

Current Trends and Innovations in Oral and Maxillofacial Reconstruction.

Eman Alfayez

Abstract readReview
In one paragraph

Review in Medical science monitor : international medical journal of experimental and clinical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Observational
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Eman AlfayezDepartment of Oral Biology, King Abdulaziz University, Jeddah, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review examines the latest advancements in maxillofacial reconstruction, focusing on transformative innovations in dentistry. Traditional surgical techniques, although effective, are accompanied by challenges such as inherent risks, complications, and inconsistent outcomes that can be influenced by variations in surgeon skill. To address these drawbacks, cutting-edge technologies have emerged, emphasizing enhanced precision, safety, and efficiency in treatment modalities. Key innovations in this field include 3-dimensional printing (additive manufacturing), virtual surgical planning, computer-aided design/computer-aided manufacturing (CAD/CAM) technology, and tissue engineering. These advancements not only revolutionize diagnostics but also streamline workflow processes, offering sustainable, timely treatments while improving therapeutic results and aesthetic outcomes. The integration of CAD/CAM technology enhances workflow efficiency by simplifying complex processes in dental prosthetic design. Simultaneously, additive manufacturing facilitates the creation of intricate dental implants with superior accuracy. Virtual surgical planning provides clinicians with valuable preoperative insights, enabling tailored surgical interventions, while tissue engineering presents regenerative solutions to complex reconstructive challenges. Despite these technological breakthroughs, the adoption of these innovations requires significant initial investments and extensive training for healthcare professionals. While logistical and financial obstacles can arise, the long-term benefits, such as enhanced patient care and superior aesthetic results, are considerable. In conclusion, this article aims to evaluate the transformative impact of digital and additive manufacturing technologies on maxillofacial reconstruction and to underscore their crucial role in advancing modern dentistry.

Indexed as

Plastic Surgery ProceduresComputer-Aided DesignDental ImplantsHumansPrinting, Three-DimensionalTissue EngineeringDental Implants

Identifiers

PMID40150813
PMCPMC11963826

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.